Volume | 7,764 |
|
|||||
News | - | ||||||
Day High | 2.59 | Low High |
|||||
Day Low | 2.4943 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
DiaMedica Therapeutics Inc | DMAC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.51 | 2.4943 | 2.59 | 2.57 | 2.53 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
109 | 7,764 | $ 2.53 | $ 19,621 | - | 1.5284 - 4.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:14 | 10 | $ 2.58 | USD |
DiaMedica Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
97.54M | 37.95M | - | 0 | -13.68M | -0.36 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
DiaMedica Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DMAC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.47 | 2.59 | 2.26 | 2.46 | 12,546 | 0.10 | 4.05% |
1 Month | 2.74 | 3.20 | 2.26 | 2.67 | 37,784 | -0.17 | -6.20% |
3 Months | 3.12 | 3.34 | 2.26 | 2.85 | 39,181 | -0.55 | -17.63% |
6 Months | 2.29 | 3.34 | 2.05 | 2.72 | 44,807 | 0.28 | 12.23% |
1 Year | 1.5284 | 4.75 | 1.5284 | 3.12 | 79,673 | 1.04 | 68.15% |
3 Years | 9.66 | 9.937 | 1.12 | 3.42 | 108,872 | -7.09 | -73.40% |
5 Years | 3.33 | 10.88 | 1.12 | 4.38 | 101,237 | -0.76 | -22.82% |
DiaMedica Therapeutics Description
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. |